NCT00777712 Mechanisms Underlying Impaired Diabetic Wound Healing
| NCT ID | NCT00777712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Non-healing Wound |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2008-09-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2008-09-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall aim of this research is to utilize wound derived inflammatory cells from diabetic versus non diabetic human chronic wounds to understand mechanisms that are responsible for disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood derived cells) versus wound derived cells will also be studied.
Eligibility Criteria
Inclusion Criteria: * Ages 21-80 * Chronic Wound (present \>4 weeks) * Diabetic \& Non-diabetic * Adult surgical wounds Exclusion Criteria: * Inability to consent * Pregnant women * Therapeutically immunocompromised * Individuals defined in 45 CFR 46 Subparts B,C, and D, nor from any other population considered vulnerable 2.9
Contact & Investigator
Sashwati Roy, Ph.D.
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT00777712 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 80 Years, studying Non-healing Wound. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00777712 currently recruiting?
Yes, NCT00777712 is actively recruiting participants. Contact the research team at pid12@pitt.edu for enrollment information.
Where is the NCT00777712 trial being conducted?
This trial is being conducted at Pittsburgh, United States, Pittsburgh, United States.
Who is sponsoring the NCT00777712 clinical trial?
NCT00777712 is sponsored by University of Pittsburgh. The principal investigator is Sashwati Roy, Ph.D. at University of Pittsburgh. The trial plans to enroll 250 participants.